Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644
- PMID: 6208356
Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644
Abstract
This study was carried out to characterize [3H]nitrendipine binding to cardiac membranes and to test the hypothesis that high affinity binding of Ca++ channel antagonists and agonists is to Ca++ channels. Binding was specific, rapid, reversible and stereoselective. The relative order of potency of nifedipine analogs for inhibition of binding was the same as that for inhibition of smooth and cardiac muscle contraction. Results with diltiazem, verapamil and lidoflazine were consistent with the hypothesis that nondihydropyridine Ca++ channel antagonists act at one or more sites allosterically linked to the 1,4-dihydropyridine site in cardiac cells. The Ca++ channel agonist Bay K 8644 [methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyr idine- 5-carboxylate] displaced specifically bound [3H]nitrendipine in an apparently competitive manner with an IC50 value of 5 nM. The results suggest that organic antagonists do not act by physically blocking the Ca++ channel. The data also support the hypothesis that the high affinity binding sites for [3H]nitrendipine in isolated cardiac membranes are associated with Ca++ channels that are inactivated or are otherwise unavailable for opening.
Similar articles
-
[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.J Pharmacol Exp Ther. 1987 Apr;241(1):140-6. J Pharmacol Exp Ther. 1987. PMID: 2437286
-
Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.J Pharmacol Exp Ther. 1983 May;225(2):291-309. J Pharmacol Exp Ther. 1983. PMID: 6842393
-
Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.J Pharmacol Exp Ther. 1986 Sep;238(3):1021-7. J Pharmacol Exp Ther. 1986. PMID: 2427685
-
Activators and inactivators of Ca++ channels: new perspectives.J Pharmacol. 1985 Oct-Dec;16(4):319-43. J Pharmacol. 1985. PMID: 2419702 Review.
-
[Biochemical and pharmacologic properties of the Ca2+ channel of skeletal muscle: appearance during myogenesis and the relation between its structure and function].J Physiol (Paris). 1986;81(3):177-84. J Physiol (Paris). 1986. PMID: 2432258 Review. French.
Cited by
-
Effect of selective agonists and antagonists on atrial adenosine receptors and their interaction with Bay K 8644 and [3H]-nitrendipine.Br J Pharmacol. 1989 Feb;96(2):372-8. doi: 10.1111/j.1476-5381.1989.tb11827.x. Br J Pharmacol. 1989. PMID: 2466519 Free PMC article.
-
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activators related to Bay K 8644 in smooth muscle, cardiac muscle and neuronal preparations.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):19-30. doi: 10.1007/BF00165121. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2471085
-
International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.Pharmacol Rev. 2014 Oct;66(4):918-47. doi: 10.1124/pr.114.008862. Pharmacol Rev. 2014. PMID: 25026896 Free PMC article.
-
Calcium channels: molecular pharmacology, structure and regulation.J Membr Biol. 1988 Sep;104(2):81-105. doi: 10.1007/BF01870922. J Membr Biol. 1988. PMID: 2903935 Review. No abstract available.
-
Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.Drugs. 1987 Feb;33(2):123-55. doi: 10.2165/00003495-198733020-00003. Drugs. 1987. PMID: 3552592 Review.